Search

Your search keyword '"Hogan, William J."' showing total 50 results

Search Constraints

Start Over You searched for: Author "Hogan, William J." Remove constraint Author: "Hogan, William J." Journal transplantation and cellular therapy Remove constraint Journal: transplantation and cellular therapy
50 results on '"Hogan, William J."'

Search Results

1. A Day 14 Endpoint for Acute GVHD Clinical Trials

2. A Validated Risk Stratification That Incorporates MAGIC Biomarkers Predicts Long-Term Outcomes in Pediatric Patients with Acute GVHD

4. Factors Predicting Survival in Patients with TP53-Mutated Myeloid Neoplasms Following Allogeneic Stem Cell Transplant

5. Ibrutinib for Therapy of Steroid-Refractory Chronic Graft Vs. Host Disease: A Multicenter Real-World Analysis

6. Coronary Artery Calcium As a Predictor of Non-Relapse Mortality and Overall Survival in Patients Undergoing Post-Transplant Cyclophosphamide As Gvhd Prophylaxis

7. Donor Search and Selection Strategy to Facilitate Comparable Transplant Rates across Donor Search Prognosis Groups: A Report from the BMT CTN 1702 Trial

8. The Mount Sinai Acute Gvhd International Consortium (MAGIC) Model: An Integrated Clinical and Biomarker Grading System for Acute Graft-Versus-Host Disease (GVHD)

10. Impact of Wilms Tumor (WT1) Mutation on Relapse and Overall Survival in Acute Myeloid Leukemia Patients Following Allogenic Stem Cell Transplantation

12. Pilot Prospective Study of Reduced Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Vexas Syndrome

13. The MAGIC Algorithm Probability Predicts Treatment Response and Long-Term Outcomes to Second-Line Therapy for Acute Gvhd

20. Prediction of Atrial Arrhythmia after Allogenic Transplantation Using Artificial Intelligence-Enabled ECG

22. Efficacy of Donor Lymphocyte Infusions in Achieving Disease Control Among Myeloid Malignancy Patients Treated with an Allogeneic Hematopoietic Stem Cell Transplantation

23. Hematopoietic Stem Cell Transplant Outcome in STAG2-Mutated Myeloid Neoplasms

24. De Novo Late Acute Gvhd: Incidence, Outcomes, and Impact of Biomarkers Compared to Classic Acute Gvhd

25. Surrogates of Endothelial Injury Predict Non-Relapse Mortality Among Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation with Post-Transplant Cyclophosphamide-Based Gvhd Prophylaxis

27. Factors Predicting Survival Following Allogeneic Stem Cell Transplant in Patients with Therapy-Related Myeloid Neoplasms

28. Clinical Outcomes of Pretransplant Mortality Prediction Models in Patients with Myelofibrosis Undergoing Allogeneic Hematopoietic Stem Cell Transplant

29. Elevated Pre-Transplant Ferritin Is Associated with Development of Liver Graft-Vs-Host Disease in Myelodysplastic Syndromes Following Allogeneic Stem Cell Transplantation

38. 32 - De Novo Late Acute Gvhd: Incidence, Outcomes, and Impact of Biomarkers Compared to Classic Acute Gvhd

39. 11 - Surrogates of Endothelial Injury Predict Non-Relapse Mortality Among Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation with Post-Transplant Cyclophosphamide-Based Gvhd Prophylaxis

48. Differences in acute graft-versus-host disease (GVHD) severity and its outcomes between Black and White patients

49. Surrogates of endothelial injury predict survival after post-transplant cyclophosphamide

50. Risk Factors and Outcomes of Nocardiosis in Hematopoietic Stem Cell Transplant Recipients

Catalog

Books, media, physical & digital resources